Recent research focusing on Retatrutide at a dosage of 30mg is shedding new light on its potential applications. Early findings suggest that this higher dosage may boost the drug's ability to manage blood glucose, potentially offering improved outcomes for individuals with type 2 diabetes. Further investigation is underway to fully evaluate the lon